The global Animal-derived Immune Globulin market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Animal-derived Immune Globulin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Animal-derived Immune Globulin market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Animal-derived Immune Globulin in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Animal-derived Immune Globulin manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Rare Disease Therapeutics
Merck
Sanofi
Wyeth Pharmaceuticals
Protherics
Genzyme
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Liquid
Powder

Segment by Application
Hospital
Clinic